Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/cclm-2012-0580PMID 23382314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comorbid and underlying diseases--major determinants of excess mortality in epilepsy.

  2012cited by this paper
• Polymorphisms in 1-Carbon Metabolism, Epigenetics and Folate-Related Pathologies

  2012cited by this paper
• Homocysteine, Vitamin B12, and Folic Acid Levels in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: Baseline Characteristics in Subjects of the Australian Imaging Biomarker Lifestyle Study

  2011cited by this paper
• Antiepileptic drugs interact with folate and vitamin B12 serum levels

  2011cited by this paper
• MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs.

  2011cited by this paper
• Homocysteine Potentiates Seizures and Cell Loss Induced by Pilocarpine Treatment

  2010cited by this paper
• Homocysteine and holotranscobalamin and the risk of Alzheimer disease

  2010cited by this paper
• Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study

  2009cited by this paper
• Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations

  2009cited by this paper
• Antiepileptic Drugs and MTHFR Polymorphisms Influence Hyper‐Homocysteinemia Recurrence in Epileptic Patients

  2007cited by this paper
• Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia

  2007cited by this paper
• An Assessment of the Potential Value of Elevated Homocysteine in Predicting Alcohol‐withdrawal Seizures

  2006cited by this paper
• Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.

  2006cited by this paper
• Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy.

  2005cited by this paper
• Life expectancy in people with newly diagnosed epilepsy.

  2004cited by this paper
• The Epidemiology of the Comorbidity of Epilepsy in the General Population

  2004cited by this paper
• New 19 bp deletion polymorphism in intron‐1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy?

  2004cited by this paper
• Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid.

  2003cited by this paper
• The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants.

  2002cited by this paper
• Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

  2002cited by this paper
• Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects

  2002cited by this paper
• Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism.

  1999cited by this paper
• A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants.

  1999cited by this paper
• A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

  1998cited by this paper
• Cause‐Specific Mortality in Epilepsy: A Cohort Study of More Than 9,000 Patients Once Hospitalized for Epilepsy

  1997cited by this paper
• High prevalence of a mutation in the cystathionine beta-synthase gene.

  1996cited by this paper
• Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

  1996cited by this paper
• Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders.

  1996cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Disorders of transsulfuration

  1989cited by this paper

• Analysis of the contribution of polymorphisms of hemostasis system genes and folate cycle genes to the genetic presposition to the development of thrombosis in patients with Ph-negative myeloproliferative neoplasia in the Republic of Uzbekistan

  2024cites this paper
• Diverse avenues of research support the transmethylation theory of psychosis: implications for neuroprotection

  2024cites this paper
• Does maternal genetic liability to folate deficiency influence the risk of antiseizure medication-associated language impairment and autistic traits in children of women with epilepsy?

  2023cites this paper
• Hyperhomocysteinemia dysregulates plasma levels of polyunsaturated fatty acids-derived eicosanoids

  2022cites this paper
• Valproate and folate: Congenital and developmental risks.

  2020cites this paper
• Antiepileptic drugs and folate revisited.

  2020cites this paper
• Role of food‑drug interactions in neurological and psychological diseases.

  2018cites this paper
• Targeting MTHFR for the treatment of migraines

  2018cites this paper
• Comparative case-control study of homocysteine, vitamin B12, and folic acid levels in patients with epilepsy.

  2017cites this paper
• Comparative case-control study of homocysteine, vitamin B12, and folic acid levels in patients with epilepsy.

  2017cites this paper
• Associations between genetic variation in one-carbon metabolism and leukocyte DNA methylation in valproate-treated patients with epilepsy.

  2017cites this paper
• Genetic Testing for Methionine Metabolism Enzymes, including MTHFR

  2017cites this paper
• Methylenetetrahydrofolate reductase gene polymorphism and clinical importance in epilepsy patients using valproic acid, carbamazepine and levetiracetam

  2017cites this paper
• Meta-analysis of the Relationship Between Plasma Homocysteine Levels and Carbamazepine Monotherapy in Patients with Epilepsy

  2017cites this paper
• Estudio comparativo de los niveles plasmáticos de homocisteína, vitamina B12 y ácido fólico en pacientes epilépticos frente a controles

  2017cites this paper
• Nutritional Aspects of Treatment in Epileptic Patients

  2016cites this paper
• Serum Homocysteine, Folate, and Vitamin B12 Levels in Carbamazepine Treated Epileptic Children.

  2016cites this paper
• Effects of Antiepileptic Drug Monotherapy on One-Carbon Metabolism and DNA Methylation in Patients with Epilepsy

  2015cites this paper
• Increased homocysteine levels in valproate-treated patients with epilepsy: a meta-analysis

  2014cites this paper
• [Effect of pharmacologic treatment of the nutritional status of neurologic patients].

  2014cites this paper
• Meta-analysis of plasma homocysteine levels in valproic acid treated patients with epilepsy

  2014cites this paper
• Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trial

  2014cites this paper
• Ist die Vitaminsubstitution bei Epilepsie-Patienten sinnvoll?

  2013cites this paper
• Autism and Dietary Therapy

  2013cites this paper
• Role of plasma homocysteine levels and MTHFR polymorphisms on IQ scores in children and young adults with epilepsy treated with antiepileptic drugs.

  2013cites this paper